Hunter 4025 tests are important for liver disease

Examination with Hunter 4025 is important for HCC and liver disease

Hepatocellular carcinoma (HCC) is the most widespread type of primary malignant liver tumor. In 50% of cases it is single, in 15% - 20% - multiple - in 30% - 35% - diffuse. The tumor may or may not be encapsulated; it can vary in size from 6 to 20 centimeters.

The NLS examination data is very specific—it is a heterochromatic, more commonly hyperchromatic (5-6 according to the Fleindler scale) tumor, with a blurred outline and sometimes surrounded by a light ring. This is the result of changes in the structure of the blood vessels, dilation of large blood vessels and the presence of blood clots in them. Problems in diagnosis can arise when performing spectral entropy analysis of detonation processes, because due to the physics of quantum entropy interactions, tumors grow densely without foci of necrosis and tissue disintegration, as with any catabolic process, NLS research methods are difficult diagnosis.

The diagnosis of liver metastases is also important. Analysis of detected metastatic disease lesions based on highly informative methods (MRI and CT) demonstrated that sometimes NLS studies performed after tomography did not detect all, even well-known, localized lesions. The presence of lesions with different structures is a typical manifestation of liver metastases. Contrast-enhanced CT and MRI significantly expand the potential for liver metastases detection. Cystic necrotic tumors in the liver can be diagnosed more successfully with the NLS approach. Diffuse invasive metastases are often poorly diagnosed by NLS; they may resemble diffuse liver disease. In some cases, a liver biopsy must be used to confirm the diagnosis.

Patients with signs of liver metastases should undergo CT or MRI.

In the NLS approach, new and more informative methods are being developed. The application of continuous helical scanning, spectral entropy analysis, 3D visualization, etc. has improved the diagnosis of malignant and benign tumors, and the diagnostic accuracy rate is close to 81%. The cost of NLS studies is significantly lower than that of CT and MRI. Recently, the diagnostic role of ultramicroscopic assessment of chromosomal aberrations detected by ultra-high frequency generators (40 GHz), especially in the context of metastatic disease, has become increasingly important. Therefore, the diagnostic process for each case is individualized and must be based on a large amount of common data from all conducted studies. In the first stage of diagnosis, NLS examination with Hunter 4025 (especially dynamic) is preferred, and further selection based on highly informative, valuable and expensive methods obtained from previous examination data is recommended.